Navigation Links
Pharmasset Reports Fiscal First Quarter 2009 Financial Results
Date:2/9/2009

---- ---- REVENUES $464,291 $464,291 -------- -------- COSTS AND EXPENSES: Research and development 14,022,930 10,550,371 General and administrative 4,069,370 2,619,745 --------- --------- Total costs and expenses 18,092,300 13,170,116 ---------- ---------- OPERATING LOSS (17,628,009) (12,705,825) INVESTMENT INCOME 109,524 896,402 INTEREST EXPENSE (756,912) (363,176) -------- -------- LOSS BEFORE INCOME TAXES (18,275,397) (12,172,599) PROVISION FOR INCOME TAXES - - --- --- NET LOSS $(18,275,397) $(12,172,599) ============ ============ COMPREHENSIVE NET LOSS: NET LOSS $(18,275,397) $(12,172,599) UNREALIZED GAIN (LOSS) ON AVAILABLE-FOR-SALE INVESTMENTS 1,089 - ----- --- COMPREHENSIVE NET LOSS $(18,274,308) $(12,172,599) ============ ============ NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS PER SHARE: BASIC $(0.78) $(0.57) DILUTED $(0.78) $(0.57) WEIGHTED AVERAGE SHARES OUTSTANDING: BASIC 23,369,487 21,263,668 DILUTED 23,369,487 21,263,668
'/>"/>
SOURCE Pharmasset, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Pharmasset Announces $45.5 Million Registered Direct Offering of Common Stock
2. Pharmasset and Roche Obtain FDA Consent to Start a Phase 2b Study With R7128 in Treatment Naive HCV Patients
3. Pharmasset to Present at Two Upcoming Investor Conferences
4. Pharmasset to Present at the Natixis Bleichroeder Hidden Gems Conference on Monday, October 13th
5. Pharmasset to Present at the JMP Securities Healthcare Focus Conference on Monday, October 6th
6. Pharmasset Reports Preliminary Results of a 4-week Proof-of-Concept Combination Study of R7128 for the Treatment of Chronic Hepatitis C in Genotype 2 or 3 Non-Responders
7. Pharmasset to Present at the Upcoming Citibank and Morgan Stanley Investor Conferences
8. Pharmasset to Present at the Canaccord Adams Global Growth Conference on Tuesday, August 12th
9. Pharmasset Announces $25.9 Million Registered Direct Offering of Common Stock
10. Pharmasset Joins Russell 3000 Index
11. Pharmasset to Present at the Needham & Co. Biotechnology and Medical Technology Conference on Wednesday, June 11th
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... and SAN JOSE, California , ... biotechnology company developing antibody-drug conjugates for cancer, today announced the ... of Directors. Dr Reynolds has over 20 years, development experience ... Officer at Seattle Genetics. "I am delighted to ...
(Date:1/15/2014)... 2014 More than 5 million Americans ... in 3 seniors will die with Alzheimer’s or another ... figures have shocked many Americans into looking for ways ... these tragic age-related cognitive disorders. Jonathan Weisman, president of ...
(Date:1/15/2014)... Scottsdale, Arizona (PRWEB) January 15, 2014 ... growth for Scottsdale’s Brain State Technologies®. They saw continued ... University Medical Center who were awarded a $1 million ... papers published in “Brain and Behavior” a peer reviewed ...
(Date:1/14/2014)... January 14, 2014 Date: Friday, April 11, ... Warrington Country Club, 1360 Almshouse Road, Warrington, Pa. ... organization solely dedicated to finding a cure for hepatitis B ... will host its annual Crystal Ball on Friday, April 11 ...
Breaking Biology Technology:Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 3Biohack Pure Offers 5 Tips for Increasing Memory in 2014 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2
... University of Wisconsin-Madison researchers led by stem-cell pioneer ... cultures under cleaner and better-defined lab conditions than ... journal Nature Biotechnology, could pave the way for ... because of animal-cell contamination. Growing stem cells in ...
... continues to make stem-cell advances , such as ... things aren't going so well elsewhere in the world: ... South Korean stem-cell researcher, fell from grace in just ... stem-cell research results. , ,Originally, the allegations against him ...
... the original story was based on an official summary that referred ... certain amendments. Under the law as enacted, the source code would ... analyzed in the case of a recount, but not open to ... it may have caused. , , Madison, Wis. ...
Cached Biology Technology:Stem-cell controversies slow progress 2Voting machine source code must be available for review 2
(Date:7/10/2014)... chronic inflammatory skin diseases psoriasis* and eczema** are similar ... to base their decision on which treatment should be ... tissue samples. A team of researchers at the Helmholtz ... have now analyzed the molecular processes that occur in ... them for the first time to gain a detailed ...
(Date:7/10/2014)... July 10, 2014Women in the West African nation ... family planning option. Sayana Press has the potential ... of the health system and in communities by ... contraceptivePfizer,s Depo-Provera (depot medroxyprogesterone acetate)with the BD Uniject ... of four African countries expected to begin introducing ...
(Date:7/9/2014)... that,s not why the Millennials are eating it, according to ... annual International Recognition Days convention July 10th in Milwaukee. , ... that are quick, easy to cook and that can help ... about any health benefits of Tofu," said lead Cornell researcher ... it,s quick to cook and it,s filling.", The study of ...
Breaking Biology News(10 mins):New diagnostic test to distinguish psoriasis from eczema 2Injectable contraceptive launched in Burkina Faso to expand choice and address unmet need 2Injectable contraceptive launched in Burkina Faso to expand choice and address unmet need 3
... LA JOLLA, Calif., September 25 2013 A new ... called medulloblastoma has been developed by researchers at Sanford-Burnham ... cellsthe cells that are critical for maintaining tumor growthand ... are essential for tumor progression. The process destroys the ...
... how their meat is sourced, with animal welfare ... many purchases. Unfortunately, many widely-used livestock production methods ... from the University of Cambridge has identified what ... silvopastoral systems which include shrubs and trees with ...
... , Sept. 25, 2013   GenoVive , an innovator ... against the emerging "globesity" epidemic through its development of ... on each individual,s unique metabolism.  "Weight Loss Designed by ... to customize an all natural meal and exercise program ...
Cached Biology News:New approach to treating human brain cancer could lead to improved outcomes 2New approach to treating human brain cancer could lead to improved outcomes 3Sustainable livestock production is possible 2Sustainable livestock production is possible 3"GenoVive is changing the face of personalized health by continuing research efforts with Harvard." 2
...
Mitochondria/Cytosol Fractionation Kit Research Focus: other Storage Temperature: 4C Shipping Temperature: 4C...
Mouse monoclonal [5H9] to RAD52 ( Abpromise for all tested applications). entrezGeneID: 5893 SwissProtID: P43351...
Polyclonal Antibody to Golgin-67...
Biology Products: